Small Cap Healthcare Stock Recommends 10% Final Dividend, Scrip Falls Over 10%; Know More

Small cap healthcare company, Prevest Denpro Ltd. in a Board meeting on Aug 04, recommended payment of Final Divide on equity share of 10% i.e. Rs 1 per equity share of face value of Rs 10/- each for the financial year 2022-23.

The Company's Board further stated that the recommended dividend is subject to the approval of shareholders of the company at AGM.

"Recommendation of payment of Final Dividend on Equity Shares at the rate of 10% (Ten per cent) [i.e.,1.00/- (Rupees One Only) per Equity Share of Face Value of 10/- (Rupees Ten Only)] for the Financial Year ended March 31, 2023., subject to approval of shareholders at the ensuing Annual General Meeting. The dividend, if approved, shall be paid within the prescribed timeline. Promoters have volunteered to waive dividend on their holdings on equity shares for the Financial Year 2022-23," the Board of Directors said in an exchange filing.

Meanwhile, Prevest Denpro's share price declined closed at Rs 454.60 per share after falling 10.15% on BSE with high and low of Rs 520 and Rs 440, respectively. It hit 52-week high on July 20, 2023, at Rs 607.50 per share, and 52-week low on Mar 14, 2023, at Rs 260.95 per share. The market cap of the stock is Rs 545.66 Crore.

The stock has fallen 17.64% in the past 1 week. It has fallen 17.60% in the past 2 weeks. In 1 month, it has fallen 14.69%. Whereas, it jumped 32.92% in 6 months. It gave 26.10% return YTD. In the past 1 year, it gave 38.81% positive return.

Disclaimer- The stock just highlights the dividend and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.